Despite the fact that additional Apc-targeting murine models have been developed (Apc∆716, Apc∆14, Apc1638N, among others), ApcMin/+ continues to be the most widely employed transgenic murine model of CRC [43]. The gene discussed is APC; the disease is colorectal carcinoma.